BI-DOSIS-NASENSPRAY

European patent · EP4382149 · In force

Register entry

Publication number
EP4382149
Application number
EP24169142
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 8, 2019
Published
Jun 12, 2024
Granted
Nov 19, 2025
Protection ends at the latest
May 7, 2039
Next annual fee due
May 31, 2027
IPC classes
A61M 15/08 (2006.01)
A61M 11/00 (2006.01)
A61M 15/00 (2006.01)
A61M 5/315 (2006.01)
G09B 23/28 (2006.01)
B65B 3/00 (2006.01)
B65B 7/16 (2006.01)
B65B 7/28 (2006.01)
B65B 31/02 (2006.01)
B65B 31/04 (2006.01)
G09B 23/30 (2006.01)
A61M 5/31 (2006.01)
Priority
CH 5752018 08.05.2018
EP 18209897 03.12.2018
Divided from
EP19721637
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 30, 2026

    Change

    Published in Swissreg on 30.09.2026

  2. Jun 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.05.2026 → 31.05.2027

    Published in Swissreg on 01.06.2026

  3. Nov 27, 2025

    Agent entered

    Representative
    Vossius & Partner, Patentanwälte Rechtsanwälte mbB, Hirschgässlein 11, 4051 Basel

    Published in Swissreg on 27.11.2025

  4. Nov 19, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 19.11.2025

Parties

Holder

AKROSWISS AG

Akroswiss AG

Baarerstrasse 2, 6301 Zug

Agent

Vossius & Partner Patentanwälte Rechtsanwälte mbB

Hirschgässlein 11, 4051 Basel

Inventor

FRÖHLICH, Johannes Malte

8702 Zollikon

ZADORY, Matthias Gergely

6301 Zug

BIENDL, Stefan Pascal

4055 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.